University of Mannheim
11
2
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
36%
4 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Motor Activity - Subjective Energy (MASE) Project
Role: collaborator
Guideline-recommended Basic Parameter Adherence in Neurocritical Care Patients
Role: collaborator
DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
Role: collaborator
Family Meal Duration and Children's Eating Behavior
Role: collaborator
Are Offline Meals Healthy Meals? A Field Experiment to Promote Healthier Eating in Families
Role: collaborator
Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain
Role: collaborator
One Year Drug Treatment in First-Episode Schizophrenia
Role: collaborator
Influence of Physostigmine on Patient-Controlled Analgesia (PCA) in Postoperative Intensive Care Patients
Role: collaborator
Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia
Role: collaborator
Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia
Role: collaborator
Optimization of Acute Treatment in First Episode Schizophrenia
Role: collaborator
All 11 trials loaded